Subscribe

Arkansas Supreme Court Overturns $1.2 Billion Judgment in Risperdal® Litigation, Citing Inadmissibility of U.S. FDA Warning Letter to Prove Consumer Protection Violations

Alert March 21, 2014

Related News & Insights